HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Visually significant haze after retreatment with photorefractive keratectomy with mitomycin-C following laser in situ keratomileusis.

Abstract
Photorefractive keratectomy (PRK) with the adjunctive use of mitomycin-C (MMC) for the treatment of residual refractive error after laser in situ keratomileusis (LASIK) has been shown to be safe and effective, with no occurrences of visually significant postoperative haze reported. We report a case of visually significant haze after PRK with MMC for residual myopia following LASIK.
AuthorsAnthony Liu, Edward E Manche
JournalJournal of cataract and refractive surgery (J Cataract Refract Surg) Vol. 36 Issue 9 Pg. 1599-601 (Sep 2010) ISSN: 1873-4502 [Electronic] United States
PMID20692575 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright (c) 2010 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Alkylating Agents
  • Mitomycin
Topics
  • Adult
  • Alkylating Agents (administration & dosage)
  • Combined Modality Therapy
  • Corneal Opacity (etiology, physiopathology)
  • Female
  • Humans
  • Keratomileusis, Laser In Situ
  • Lasers, Excimer
  • Mitomycin (administration & dosage)
  • Myopia (surgery)
  • Photorefractive Keratectomy (adverse effects)
  • Reoperation
  • Vision Disorders (etiology, physiopathology)
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: